Opioid overdose is now the leading cause of accidental death in the United States. Fatalities and injuries are not limited to opioids however adverse drug events related to pharmaceuticals are the largest contributor to hospital-related complications and account for more than 3.5 million physician office visits each year. As a result of increased attention to reduce and prevent the dangers associated with adverse drug events, the U.S. Department of Health & Human Services (HHS), in partnership with the U.S. Department of Defense, U.S. Department of Veterans Affairs, and the U.S. Bureau of Prisons has developed the National Action Plan for Adverse Drug Event Prevention.
HHS currently seeks feedback from a wide array of stakeholders including organizations and professional groups on the draft version of the National Action Plan for Adverse Drug Event Prevention. As a substantial portion of this document addresses opioids, it is very important that the voice of addictions and pain treatment professionals be heard with regard to this document.
The public comment period will be open from September 4 to 5pm on October 3, 2013.
To participate in this public comment period, visit: http://1.usa.gov/15fSxvQ.